Aerovate Therapeutics Net Worth 2020-2024 | JBIO
Interactive chart of historical net worth (market cap) for Aerovate Therapeutics (JBIO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Aerovate Therapeutics net worth as of May 01, 2025 is $0.01B.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.008B |
$0.000B |
|
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.
|
